| 1 (33) | Regeneron Pharmaceuticals Inc * | USA |  |
| 2 (36) | Janssen | MUL | |
| 3 (46) | Johnson & Johnson * | MUL | |
| 4 (56) | Janssen Biotech Inc | USA | |
| 5 (99) | Eli Lilly * | MUL | |
| 6 (108) | Sanofi * | MUL | |
| 7 (109) | Samsung Corp * | MUL | |
| 8 (118) | Pfizer Inc, United States | USA | |
| 9 (126) | Pfizer * | MUL | |
| 10 (150) | Eli Lilly and Company, United States | USA | |
| 11 (152) | AbbVie * | MUL | |
| 12 (154) | Sanofi, United States | USA | |
| 13 (164) | AbbVie Inc, United States | USA | |
| 14 (180) | Novartis * | MUL | |
| 15 (217) | Novartis, Switzerland | CHE | |
| 16 (622) | Anima Holding SA * | BRA | |
| 17 (776) | Manipal Global Education Group * | MUL | |
| 18 (820) | Novo Nordisk * | MUL | |
| 19 (899) | Novo Nordisk A/S | DNK | |
| 20 (932) | Novartis Pharmaceuticals, United States | USA | |
| 21 (1123) | Pfizer Inc, United Kingdom | GBR | |
|
